|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.660 SEK | -2.40% |
|
0.00% | +148.98% |
| 23/07 | Sprint Bioscience AB and Eli Lilly and Company Enter Agreement to Accelerate Drug Development | CI |
| 26/06 | Four stocks have so far today posted new 52-week highs on the Stockholm Stock Exchange | FW |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 4.08 | 4.49 | 4.45 |
| Spread/Res. | -10.29% | -18.49% | -17.75% |
| Spread/Supp. | +3.39% | +46.40% | +131.65% |
| Support | 3.54 | 2.5 | 1.58 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SPRINT Stock
- Charts Sprint Bioscience AB
Select your edition
All financial news and data tailored to specific country editions
